Stockholm - Delayed Quote SEK
CHOSA Oncology AB (CHOSA.ST)
0.5850
-0.0300
(-4.88%)
At close: June 13 at 5:29:30 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-7,867
-7,867
1,202
-494
-49,137.0460
Investing Cash Flow
0
0
15,121
-37
-10,107.5160
Financing Cash Flow
5,534
5,534
-8,516
1,497
470
End Cash Position
6,438
6,438
8,772
966
29,620.7060
Capital Expenditure
--
--
--
-37
--
Issuance of Capital Stock
5,585
5,585
6,464
1,497
470
Issuance of Debt
--
--
--
14,979.7600
0
Repayment of Debt
0
0
-14,980
0
--
Free Cash Flow
-7,867
-7,867
1,202
-531
-49,137.0460
12/31/2021 - 3/9/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HMGN Hemagen Diagnostics, Inc.
0.0001
0.00%
DBP-B.ST Double Bond Pharmaceutical Int.
0.1150
-8.73%
ERGO Entia Biosciences, Inc.
0.0001
0.00%
XSPRAY.ST Xspray Pharma AB (publ)
35.50
+3.50%
2CUREX.ST 2cureX AB (publ)
4.4400
-2.20%
ISOFOL.ST Isofol Medical AB (publ)
1.0450
-8.97%
KAN.ST Kancera AB (publ)
1.1340
+6.58%
ONCO.ST Oncopeptides AB (publ)
1.4700
-3.29%
ACTI.ST Active Biotech AB (publ)
0.2385
-4.22%
LOBEF Lobe Sciences Ltd.
0.0023
-11.54%